Edition:
United Kingdom

Caladrius Biosciences Inc (CLBS.OQ)

CLBS.OQ on NASDAQ Stock Exchange Capital Market

2.63USD
24 Jun 2019
Change (% chg)

-- (--)
Prev Close
$2.63
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
6,567
52-wk High
$7.57
52-wk Low
$2.50

About

Caladrius Biosciences, Inc. is a cell therapy development company with product candidates in development based on multiple technology platforms and targeting autoimmune and cardiology indications. The Company's lead product candidate, CLBS03, is a T regulatory cell (Treg) clinical Phase II therapy targeting adolescents with... (more)

Overall

Beta: 1.45
Market Cap(Mil.): $27.31
Shares Outstanding(Mil.): 10.38
Dividend: --
Yield (%): --

Financials

  CLBS.OQ Industry Sector
P/E (TTM): -- 106.18 37.40
EPS (TTM): -1.59 -- --
ROI: -36.38 7.76 12.12
ROE: -38.73 8.32 17.02

Earnings vs. Estimates